Tumours not expressing the oestrogen receptor (ER) or progesterone receptor (PR) and have no human epidermal growth factor receptor 2 (HER2; also referred to by its gene name ERBB2) amplification are classified as triple-negative breast cancer (TNBC) [105]. The gene discussed is PGR; the disease is neoplasm.